Steven P. Vickers

1.6k total citations
28 papers, 1.3k citations indexed

About

Steven P. Vickers is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Steven P. Vickers has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cellular and Molecular Neuroscience, 11 papers in Molecular Biology and 11 papers in Pharmacology. Recurrent topics in Steven P. Vickers's work include Neurotransmitter Receptor Influence on Behavior (8 papers), Regulation of Appetite and Obesity (7 papers) and Biochemical Analysis and Sensing Techniques (7 papers). Steven P. Vickers is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (8 papers), Regulation of Appetite and Obesity (7 papers) and Biochemical Analysis and Sensing Techniques (7 papers). Steven P. Vickers collaborates with scholars based in United Kingdom, United States and Germany. Steven P. Vickers's co-authors include Peter G. Clifton, Colin T. Dourish, G.A. Kennett, Laurence H. Tecott, Sharon C. Cheetham, Elizabeth M. Somerville, Helen C. Jackson, David J. Heal, Peter H. Hutson and Keith Dickinson and has published in prestigious journals such as Diabetes, Journal of Controlled Release and British Journal of Pharmacology.

In The Last Decade

Steven P. Vickers

28 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven P. Vickers United Kingdom 19 492 485 378 293 278 28 1.3k
Daniel I. Brierley United Kingdom 14 284 0.6× 677 1.4× 242 0.6× 267 0.9× 142 0.5× 16 1.5k
Nuria Del Olmo Spain 26 339 0.7× 980 2.0× 266 0.7× 556 1.9× 204 0.7× 69 1.8k
Laura Orío Spain 23 116 0.2× 605 1.2× 492 1.3× 226 0.8× 136 0.5× 60 1.6k
Michael A. Statnick United States 26 580 1.2× 1.2k 2.4× 149 0.4× 567 1.9× 187 0.7× 43 2.0k
Nuno J. Machado Portugal 21 123 0.3× 548 1.1× 257 0.7× 432 1.5× 91 0.3× 28 1.9k
Angelo Blasio United States 16 181 0.4× 403 0.8× 240 0.6× 123 0.4× 59 0.2× 22 938
María Scherma Italy 26 176 0.4× 1.3k 2.6× 1.2k 3.2× 244 0.8× 92 0.3× 67 2.1k
Frédérique Chaperon Switzerland 16 195 0.4× 1.3k 2.7× 975 2.6× 177 0.6× 111 0.4× 22 1.9k
Michal Bajo United States 24 183 0.4× 960 2.0× 169 0.4× 260 0.9× 76 0.3× 55 1.9k
Ignacio del Arco Spain 16 290 0.6× 1.1k 2.3× 1.6k 4.3× 255 0.9× 124 0.4× 19 2.2k

Countries citing papers authored by Steven P. Vickers

Since Specialization
Citations

This map shows the geographic impact of Steven P. Vickers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven P. Vickers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven P. Vickers more than expected).

Fields of papers citing papers by Steven P. Vickers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven P. Vickers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven P. Vickers. The network helps show where Steven P. Vickers may publish in the future.

Co-authorship network of co-authors of Steven P. Vickers

This figure shows the co-authorship network connecting the top 25 collaborators of Steven P. Vickers. A scholar is included among the top collaborators of Steven P. Vickers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven P. Vickers. Steven P. Vickers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dedic, Nina, Lien Wang, Éva Hajós‐Korcsok, et al.. (2024). TAAR1 agonists improve glycemic control, reduce body weight and modulate neurocircuits governing energy balance and feeding. Molecular Metabolism. 80. 101883–101883. 11 indexed citations
2.
Galvin, Orla, Akshay Srivastava, Oliver Carroll, et al.. (2016). A sustained release formulation of novel quininib-hyaluronan microneedles inhibits angiogenesis and retinal vascular permeability in vivo. Journal of Controlled Release. 233. 198–207. 28 indexed citations
3.
Jones, Robert B., et al.. (2014). Effect of linagliptin, alone and in combination with voglibose or exendin-4, on glucose control in male ZDF rats. European Journal of Pharmacology. 729. 59–66. 13 indexed citations
4.
Vickers, Steven P., Sharon C. Cheetham, Keith Dickinson, et al.. (2014). Combination of the sodium-glucose cotransporter-2 inhibitor empagliflozin with orlistat or sibutramine further improves the body-weight reduction and glucose homeostasis of obese rats fed a cafeteria diet. Diabetes Metabolic Syndrome and Obesity. 7. 265–265. 55 indexed citations
5.
Vickers, Steven P. & Peter G. Clifton. (2012). Animal models to explore the effects of CNS drugs on food intake and energy expenditure. Neuropharmacology. 63(1). 124–131. 11 indexed citations
6.
Vickers, Steven P., Sharon C. Cheetham, Helen L. Rowley, et al.. (2012). Effects of the DPP-4 Inhibitor, Linagliptin, in Diet-Induced Obese Rats: A Comparison in Naive and Exenatide-Treated Animals. Clinical Laboratory. 59(01+02/2013). 787–99. 11 indexed citations
7.
Vickers, Steven P., Helen C. Jackson, & Sharon C. Cheetham. (2011). The utility of animal models to evaluate novel anti‐obesity agents. British Journal of Pharmacology. 164(4). 1248–1262. 81 indexed citations
8.
Hadden, Mark, Alan J. Henderson, M. D. Surman, et al.. (2010). Synthesis and SAR of 4-aryl-1-(indazol-5-yl)pyridin-2(1H)ones as MCH-1 antagonists for the treatment of obesity. Bioorganic & Medicinal Chemistry Letters. 20(23). 7020–7023. 11 indexed citations
9.
Surman, M. D., Emily Freeman, Mark Hadden, et al.. (2010). 5-(Pyridinon-1-yl)indazoles and 5-(furopyridinon-5-yl)indazoles as MCH-1 antagonists. Bioorganic & Medicinal Chemistry Letters. 20(23). 7015–7019. 14 indexed citations
10.
Henderson, Alan J., Mark Hadden, Yuri L. Khmelnitsky, et al.. (2010). Tetrahydrocarboline analogs as MCH-1 antagonists. Bioorganic & Medicinal Chemistry Letters. 20(23). 7024–7028. 10 indexed citations
11.
12.
Kennett, G.A., Karen Benwell, Dean F. Revell, et al.. (2006). The cannabinoid CB1 receptor inverse agonist, rimonabant, modifies body weight and adiponectin function in diet-induced obese rats as a consequence of reduced food intake. Pharmacology Biochemistry and Behavior. 84(2). 353–359. 73 indexed citations
13.
Vickers, Steven P., et al.. (2005). SR141716A reduces appetitive and consummatory responses for food.. Journal of Analytical Toxicology. 4(2). 49–53. 1 indexed citations
14.
Adams, David R., Jonathan Bentley, Karen Benwell, et al.. (2005). Pyrrolo(iso)quinoline derivatives as 5-HT2C receptor agonists. Bioorganic & Medicinal Chemistry Letters. 16(3). 677–680. 20 indexed citations
15.
Vickers, Steven P., et al.. (2004). The cannabinoid CB1 receptor antagonist SR141716A reduces appetitive and consummatory responses for food. Psychopharmacology. 179(2). 452–460. 74 indexed citations
16.
Adams, David, Sven Taylor, Stephan Röver, et al.. (2004). 5-HT2C Receptor Agonists for the Treatment of Obesity. Biological and Chemical Adventures. CHIMIA International Journal for Chemistry. 58(9). 613–613. 18 indexed citations
17.
Vickers, Steven P., Colin T. Dourish, & G.A. Kennett. (2001). Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors. Neuropharmacology. 41(2). 200–209. 164 indexed citations
18.
Bickerdike, Mike, Steven P. Vickers, & Colin T. Dourish. (1999). 5‐HT 2C receptor modulation and the treatment of obesity. Diabetes Obesity and Metabolism. 1(4). 207–214. 34 indexed citations
19.
Vickers, Steven P., Peter G. Clifton, Colin T. Dourish, & Laurence H. Tecott. (1999). Reduced satiating effect of d -fenfluramine in serotonin 5-HT 2C receptor mutant mice. Psychopharmacology. 143(3). 309–314. 235 indexed citations
20.
Clifton, Peter G., Steven P. Vickers, & Elizabeth M. Somerville. (1998). Little and often: Ingestive behavior patterns following hippocampal lesions in rats.. Behavioral Neuroscience. 112(3). 502–511. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel I. Brierley Breakdown of academic impact, for papers by Nuria Del Olmo Breakdown of academic impact, for papers by Laura Orío Breakdown of academic impact, for papers by Michael A. Statnick Breakdown of academic impact, for papers by Nuno J. Machado Breakdown of academic impact, for papers by Angelo Blasio Breakdown of academic impact, for papers by María Scherma Breakdown of academic impact, for papers by Frédérique Chaperon Breakdown of academic impact, for papers by Michal Bajo Breakdown of academic impact, for papers by Ignacio del Arco
Rankless by CCL
2026